Delivery Order SPE2DB22D1106-SPE2DB25FEDT4
- Not listed
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,834.51 firm fixed-price contract is for the supply of Hydrocortisone-Pramoxine 2.5-1% cream, a topical medication. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2023. There was no set-aside designation, indicating the contract was open to full and open competition....
- This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,531.55, is for the supply of Hydrocortisone 1% Cream in 28.35 gram tubes. The contract is a firm fixed-price delivery order with a completion date of May 9, 2024. This contract award is not associated with a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydrocortisone-Pramoxine 2.5-1% Cream, a topical medication, and has a ceiling value of $1,515.64. The contract has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYDROCORTISONE 1% CREAM 28.35GM, a medical product, with a firm fixed-price of $1,190.10 and a completion date of May 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime...
- This is a Delivery Order award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.56 firm fixed-price award is for the supply of a pharmaceutical product, Hydrocortisone-Pramoxine 2.5-1% Cream, 28.4 grams. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.55 firm fixed-price delivery order is for the supply of Hydrocortisone-Pramoxine 2.5-1% Cream, a medical product used for various skin conditions. The award is not designated as a set-aside, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,622.91 to AmerisourceBergen Drug Corp for the supply of 4567330281 - Hydrocortisone 1% Cream 28.4GM. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs...
- The Defense Logistics Agency awarded a delivery order valued at $1,464.46 to AmerisourceBergen Drug Corp for Hydrocortisone-Pramoxine 2.5-1% cream in 30-gram units. This firm fixed price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product - Hydrocort-Pramoxine 2.5-1% Cream 30GM. The $2,002.93 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive range of...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEDT4Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,133.59, is for the supply of Hydrocortisone-Pramoxine 2.5-1% Cream (28.4 grams). The award does not have a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 3/18/25 |